151 related articles for article (PubMed ID: 25925627)
1. Laparoscopic hysterectomy: weigh harms, but do not dismiss benefits.
Nygaard I
Am J Obstet Gynecol; 2015 May; 212(5):553-5. PubMed ID: 25925627
[No Abstract] [Full Text] [Related]
2. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis.
Siedhoff MT; Wheeler SB; Rutstein SE; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL
Am J Obstet Gynecol; 2015 May; 212(5):591.e1-8. PubMed ID: 25817518
[TBL] [Abstract][Full Text] [Related]
3. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
4. Alterations in surgical technique after FDA statement on power morcellation.
Desai VB; Guo XM; Xu X
Am J Obstet Gynecol; 2015 May; 212(5):685-7. PubMed ID: 25735888
[No Abstract] [Full Text] [Related]
5. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
6. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
7. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Parker W; Pritts E; Olive D
J Minim Invasive Gynecol; 2015; 22(4):696-7. PubMed ID: 25623370
[No Abstract] [Full Text] [Related]
8. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.
Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407
[TBL] [Abstract][Full Text] [Related]
9. FDA warns against power morcellation for hysterectomy and fibroids.
Wallis L
Am J Nurs; 2014 Jul; 114(7):16. PubMed ID: 25742335
[No Abstract] [Full Text] [Related]
10. The Morcellation Debate: The History and the Science.
Adelman MR
Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
[TBL] [Abstract][Full Text] [Related]
11. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
Tulandi T; Leung A; Jan N
J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909
[TBL] [Abstract][Full Text] [Related]
12. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
13. Reply: To PMID 25460521.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(4):697. PubMed ID: 25623372
[No Abstract] [Full Text] [Related]
14. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe?
Hinchcliff EM; Cohen SL
Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
[TBL] [Abstract][Full Text] [Related]
17. Contained tissue extraction using power morcellation: prospective evaluation of leakage parameters.
Cohen SL; Morris SN; Brown DN; Greenberg JA; Walsh BW; Gargiulo AR; Isaacson KB; Wright KN; Srouji SS; Anchan RM; Vogell AB; Einarsson JI
Am J Obstet Gynecol; 2016 Feb; 214(2):257.e1-257.e6. PubMed ID: 26348384
[TBL] [Abstract][Full Text] [Related]
18. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
19. Role of robotic surgery in treating fibroids and benign uterine mass.
Kim S; Luu TH; Llarena N; Falcone T
Best Pract Res Clin Obstet Gynaecol; 2017 Nov; 45():48-59. PubMed ID: 28551090
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment: Myomectomy and hysterectomy; Endoscopy: A major advancement.
Thubert T; Foulot H; Vinchant M; Santulli P; Marzouk P; Borghese B; Chapron C
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():104-21. PubMed ID: 27400649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]